Literature DB >> 1977518

Tumor progression in four mammary epithelial cell lines derived from the same patient.

V Band1, D Zajchowski, K Swisshelm, D Trask, V Kulesa, C Cohen, J Connolly, R Sager.   

Abstract

Two primary and two metastatic cell lines with distinct phenotypes and genotypes have been established from a patient diagnosed as having infiltrating and intraductal mammary carcinoma (21T series). All four lines can be cultured in the same medium, DFCI-1, which also supports long-term growth of normal epithelial cells. Therefore, we have been able to compare normal and tumor cells at the cellular and molecular levels. The mammary origin of the 21T series was confirmed by using antibodies against the human milk fat globule antigen-2 epitope. The two primary tumor lines (21NT and 21PT) are both immortal and aneuploid, although only 21NT is tumorigenic in the nude mouse assay. The two populations derived from the metastatic pleural effusion (21MT-1 and 21MT-2) each exhibit distinct characteristics in morphology and growth factor requirements. The erbB2 gene is amplified and overexpressed in all of these cell lines compared to normal epithelial cell controls. These four tumor cell lines from a single patient represent a mammary tumor progression series that has been established in long-term cell culture.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1977518

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  66 in total

Review 1.  Structural cues from the tissue microenvironment are essential determinants of the human mammary epithelial cell phenotype.

Authors:  K L Schmeichel; V M Weaver; M J Bissell
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

Review 2.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

3.  A bcl-xS adenovirus selectively induces apoptosis in transformed cells compared to normal mammary cells.

Authors:  V N Sumantran; D S Lee; K M Woods Ignatoski; S P Ethier; M S Wicha
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

4.  Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment.

Authors:  S W Lee; C Tomasetto; K Swisshelm; K Keyomarsi; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

5.  Tyrosine phosphorylation of the Gα-interacting protein GIV promotes activation of phosphoinositide 3-kinase during cell migration.

Authors:  Changsheng Lin; Jason Ear; Yelena Pavlova; Yash Mittal; Irina Kufareva; Majid Ghassemian; Ruben Abagyan; Mikel Garcia-Marcos; Pradipta Ghosh
Journal:  Sci Signal       Date:  2011-09-27       Impact factor: 8.192

6.  Effects of Transcription Elongation Rate and Xrn2 Exonuclease Activity on RNA Polymerase II Termination Suggest Widespread Kinetic Competition.

Authors:  Nova Fong; Kristopher Brannan; Benjamin Erickson; Hyunmin Kim; Michael A Cortazar; Ryan M Sheridan; Tram Nguyen; Shai Karp; David L Bentley
Journal:  Mol Cell       Date:  2015-10-15       Impact factor: 17.970

7.  Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models.

Authors:  Swapnil S Desale; Srikumar M Raja; Jong Oh Kim; Bhopal Mohapatra; Kruti S Soni; Haitao Luan; Stetson H Williams; Timothy A Bielecki; Dan Feng; Matthew Storck; Vimla Band; Samuel M Cohen; Hamid Band; Tatiana K Bronich
Journal:  J Control Release       Date:  2015-02-03       Impact factor: 9.776

8.  Expression of GIV/Girdin, a metastasis-related protein, predicts patient survival in colon cancer.

Authors:  Mikel Garcia-Marcos; Barbara H Jung; Jason Ear; Betty Cabrera; John M Carethers; Pradipta Ghosh
Journal:  FASEB J       Date:  2010-10-25       Impact factor: 5.191

9.  Acquisition of in vitro growth autonomy during B16 melanoma malignant progression is associated with autocrine stimulation by transferrin and fibronectin.

Authors:  C W Stackpole; S S Kalbag; L Groszek
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-03       Impact factor: 2.416

10.  Positive selection of candidate tumor-suppressor genes by subtractive hybridization.

Authors:  S W Lee; C Tomasetto; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.